{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:22:35Z","timestamp":1760170955116},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"commercial or non-commercial organization"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jpsychores.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychosomatic Research"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.jpsychores.2015.09.011","type":"journal-article","created":{"date-parts":[[2015,9,27]],"date-time":"2015-09-27T03:43:55Z","timestamp":1443325435000},"page":"530-532","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Is major depression associated with serum levels of tumor necrosis factor-alpha in patients with rheumatoid arthritis?"],"prefix":"10.1016","volume":"79","author":[{"given":"Faruk","family":"Uguz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adem","family":"Kucuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Semra","family":"Aydogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sevket","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hat\u0131ce Guncu","family":"Kurt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aysun","family":"Toker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammed","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychores.2015.09.011_bb0005","first-page":"735","article-title":"Factors affecting depression and anxiety in female Japanase patients with rheumatoid arthritis","volume":"18","author":"Takeda","year":"2000","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jpsychores.2015.09.011_bb0010","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s10067-005-0106-0","article-title":"Clinical significance of IL-18, IL-15, IL-12 and TNF-\u03b1 measurement in rheumatoid arthritis","volume":"25","author":"Petrovic-Rackov","year":"2006","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jpsychores.2015.09.011_bb0015","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.autrev.2004.09.002","article-title":"Epidemiology of adult rheumatoid arthritis","volume":"4","author":"Alamanos","year":"2005","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jpsychores.2015.09.011_bb0020","first-page":"7","article-title":"Etiology and pathogenesis of rheumatoid arthritis","volume":"2","author":"Fresko","year":"2006","journal-title":"Turk. Klin. J In. Med Sci"},{"key":"10.1016\/j.jpsychores.2015.09.011_bb0025","first-page":"12","article-title":"Clinical features of rheumatoid arthritis","volume":"2","author":"Hatemi","year":"2006","journal-title":"Turk. Klin. J Int Med Sci"},{"key":"10.1016\/j.jpsychores.2015.09.011_bb0030","first-page":"952","article-title":"Health related quality of life in women with elderly onset rheumatoid arthritis","volume":"30","author":"Mikuls","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jpsychores.2015.09.011_bb0035","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1093\/rheumatology\/ket169","article-title":"The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis","volume":"52","author":"Matcham","year":"2013","journal-title":"Rheumatology"},{"key":"10.1016\/j.jpsychores.2015.09.011_bb0040","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1176\/appi.psy.44.3.209","article-title":"Association of depression and rheumatoid arthritis","volume":"44","author":"Dickens","year":"2003","journal-title":"Psychosomatics"},{"key":"10.1016\/j.jpsychores.2015.09.011_bb0045","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/rheumatology\/37.4.391","article-title":"Depression and depressive symptoms in rheumatoid arthritis patients: an analysis of their occurence and determinants","volume":"37","author":"Abdel-Nasser","year":"1998","journal-title":"Br. J. Rheumatol."},{"key":"10.1016\/j.jpsychores.2015.09.011_bb0050","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.4088\/JCP.v67n0807","article-title":"Comorbidity of fibromyalgia and psychiatric disorders","volume":"67","author":"Arnold","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jpsychores.2015.09.011_bb0055","first-page":"920","article-title":"Depression in rheumatoid artrhritis","volume":"15","author":"Frank","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jpsychores.2015.09.011_bb0060","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S1297-319X(02)00368-8","article-title":"Is anxiety a more common disorder than depression in rheumatoid arthritis?","volume":"69","author":"El-Miedany","year":"2002","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jpsychores.2015.09.011_bb0065","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1440-1819.2008.01905.x","article-title":"Anti-tumor necrosis factor-\u03b1 therapy is associated with less frequent mood and anxiety disorders in patients with rheumatoid arthritis","volume":"63","author":"Uguz","year":"2009","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.jpsychores.2015.09.011_bb0070","first-page":"395","article-title":"Psychiatric comorbidity and work disability in patients with inflammatory rheumatic diseases","volume":"66","author":"L\u00f6we","year":"2004","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.jpsychores.2015.09.011_bb0075","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0022-3999(98)00073-7","article-title":"Depression, illness perception and coping in rheumatoid arthritis","volume":"46","author":"Murphy","year":"1999","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.jpsychores.2015.09.011_bb0080","first-page":"1013","article-title":"Comorbid depression is an independent risk factor for mortality in patients with rheumatoid arthritis","volume":"32","author":"Ang","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jpsychores.2015.09.011_bb0085","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/ard.62.5.472","article-title":"Circulating tumour necrosis factor \u03b1 and soluble tumour necrosis factor receptors in patients with different patterns of rheumatoid synovitis","volume":"62","author":"Klimiuk","year":"2003","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jpsychores.2015.09.011_bb0090","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1756-185X.2011.01673.x","article-title":"The role of interleukin (IL)-17 in anxiety and depression of patients with rheumatoid arthritis","volume":"15","author":"Liu","year":"2012","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.jpsychores.2015.09.011_bb0095","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2169\/internalmedicine.42.15","article-title":"Anti-TNF-\u03b1 therapy for rheumatoid arthritis: an update","volume":"42","author":"Taylor","year":"2003","journal-title":"Intern. Med."},{"key":"10.1016\/j.jpsychores.2015.09.011_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2015.03.019","article-title":"Rheumatoid arthritis: biological therapy other than anti-TNF","author":"Rossi","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jpsychores.2015.09.011_bb0105","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.18553\/jmcp.2011.17.s9-b.S14","article-title":"Biologic agents in rheumatoid arthritis: an update for managed care professionals","volume":"17","author":"Agarwal","year":"2011","journal-title":"J. Manag. Care Pharm."},{"key":"10.1016\/j.jpsychores.2015.09.011_bb0110","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00213-003-1566-z","article-title":"Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder","volume":"170","author":"Tuglu","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jpsychores.2015.09.011_bb0115","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.psyneuen.2014.03.019","article-title":"The plasma levels of various cytokines are increased during ongoing depression anda re reduced to normal levels after recovery","volume":"45","author":"Dahl","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.jpsychores.2015.09.011_bb0120","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpsychores.2015.09.011_bb0125","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jad.2014.07.032","article-title":"A review of the relationship between proinflammatory cytokines and major depressive disorder","volume":"169","author":"Young","year":"2014","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jpsychores.2015.09.011_bb0130","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1752-1947-5-112","article-title":"Sustained remission of rheumatoid arthritis with a specific serotonin reuptake inhibitor atidepressant: a case report and review of the literature","volume":"5","author":"Krishnadas","year":"2011","journal-title":"J. Med. Case Rep."},{"key":"10.1016\/j.jpsychores.2015.09.011_bb0135","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1159\/000339109","article-title":"Immunomodulatory effect of sertraline in a rat model of rheumatoid arthritis","volume":"19","author":"Baharav","year":"2012","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.jpsychores.2015.09.011_bb0140","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1093\/rheumatology\/kep170","article-title":"Depression in RA patients treated with anti-TNF is common and under-recognized in the rheumatology clinic","volume":"48","author":"Hider","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.jpsychores.2015.09.011_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpsychores.2015.04.008","article-title":"Tumour necrosis factor-\u03b1 inhibitor therapy in chronic physical illness: a systematic review and meta-analysis of the effect on depression and anxiety","author":"Abbott","year":"2015","journal-title":"J. Psychosom. Res."},{"key":"10.1016\/j.jpsychores.2015.09.011_bb0150","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jpsychores.2015.09.011_bb0155","series-title":"Structured Clinical Interview for DSM-IV Clinical Version (SCID-I\/CV)","author":"First","year":"1997"},{"key":"10.1016\/j.jpsychores.2015.09.011_bb0160","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/archpsyc.1988.01800320058007","article-title":"A structured interview guide for Hamilton Depression Rating Scale","volume":"45","author":"Williams","year":"1978","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jpsychores.2015.09.011_bb0165","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","article-title":"The assessment of anxiety states by rating","volume":"32","author":"Hamilton","year":"1959","journal-title":"Br J Med Psychol"},{"key":"10.1016\/j.jpsychores.2015.09.011_bb0170","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1600-0447.1993.tb03411.x","article-title":"One-month prevalence of mental disorders in the United States and sociodemographic characteristics: the Epidemiologic Catchment Area Study","volume":"88","author":"Regier","year":"1993","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jpsychores.2015.09.011_bb0175","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1192\/bjp.184.4.299","article-title":"Population prevalence of psychiatric disorders in Chile: 6-month and 1-month rates","volume":"84","author":"Vicente","year":"2004","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jpsychores.2015.09.011_bb0180","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s001270050098","article-title":"Prevalence of psychiatric disorder in the general population: results of The Netherlands Mental Health Survey and Incidence Study (NEMESIS)","volume":"33","author":"Bijl","year":"1998","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"10.1016\/j.jpsychores.2015.09.011_bb0185","first-page":"1","article-title":"Psychiatric morbidity associated with some sytokines (IL-1beta, IL-12, IL-18 and TNF-alpha) among rheumatoid arthritis patients","volume":"15","author":"El-Tantawy","year":"2008","journal-title":"Egypt J Immunol"},{"key":"10.1016\/j.jpsychores.2015.09.011_bb0190","doi-asserted-by":"crossref","first-page":"198","DOI":"10.4269\/ajtmh.2008.78.198","article-title":"Cerebrospinal fluid cytokine levels and cognitive impairment in cerebral malaria","volume":"78","author":"John","year":"2008","journal-title":"Am.J.Trop. Med. Hyg."}],"container-title":["Journal of Psychosomatic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022399915005486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022399915005486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,8]],"date-time":"2020-09-08T21:28:56Z","timestamp":1599600536000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022399915005486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S0022399915005486"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychores.2015.09.011","relation":{},"ISSN":["0022-3999"],"issn-type":[{"value":"0022-3999","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is major depression associated with serum levels of tumor necrosis factor-alpha in patients with rheumatoid arthritis?","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychosomatic Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychores.2015.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}